Do Systemically Administered Glutamate Antagonists Affect Subthalamic Nucleus Activity?
Relevance to pharmacotherapy of Parkinson’s disease
Part of the Advances in Behavioral Biology book series (ABBI, volume 56)
KeywordsNMDA Receptor Deep Brain Stimulation Globus Pallidus Subthalamic Nucleus NMDA Antagonist
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Blanchet, P.J., Konitsiotis, S., Whittemore, E.R., Zhou, Z.L., Woodward, R.M., and Chase, T.N., 1999, Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys, J. Pharmacol. Exp. Ther. 290:1034.PubMedGoogle Scholar
- Breit, S., Bouali-Benazzouz, R., Benabid, A.L., and Benazzouz, A., 2001, Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat, Eur. J. Neurosci. 14:1833.PubMedCrossRefGoogle Scholar
- Clineschmidt, B.V., Martin, G.E., Bunting, P.R., and Papp, N.L., 1982, Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties, Drug. Dev. Res. 2:135.CrossRefGoogle Scholar
- Dunah, A.W., Wang, Y.H., Yasuda, R.P., Kameyama, K., Huganir, R.L., Wolfe, B.B., and Standaert, D.G., 2000, Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-Daspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson’s disease, Mol. Pharmacol. 57:342.PubMedGoogle Scholar
- Hu, D., Itoga C.A., Bergstrom, D.A., Parr-Brownlie, L.C., Ghiglieri V., and Walters, J.R., 2004, Increased patterned activity in basal ganglia outputs is organized by coordinated oscillations in the indirect pathway after dopamine loss in anesthetized rats, Soc. Neurosci. Abstr. 309:8.Google Scholar
- Metman, L.V., Del Dotto, P., Van den Munckhof, P., Fang, J., Mouradian, M.M., and Chase, T.N., 1998b, Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease, Neurology 50:1323.Google Scholar
- Miller, W.C., and Delong, M.R., 1987, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MTPTP model of parkinsonism, in: The Basal Ganglia II, M.B. Carpenter and A. Jayaraman, eds., Plenum Press, New York, pp. 415–427.Google Scholar
- Tai, C.H., Boraud, T., Bezard, E., Bioulac, B., Gross, C., and Benazzouz, A., 2003, Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata, FASEB J. 17:1820.PubMedCrossRefGoogle Scholar
- Vila, M., Perier, C., Feger, J., Yelnik, J., Faucheux, B., Ruberg, M., Raisman-Vozari, R., Agid, Y., and Hirsch, E.C., 2000, Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements, Eur. J. Neurosci. 12:337.PubMedCrossRefGoogle Scholar
- Walters, J.R., Hu, D., Itoga, C.A., Parr-Brownlie, L.C., and Bergstrom, D.A., Do local field potentials reflect synchronized spiking activity of neuronal populations in the basal ganglia? Studies in a rodent model of Parkinson’s disease, in: The Basal Ganglia VIII, J.P. Bolam, P.J. Magill, and C. Ingham, eds., Springer Science and Business Media, New York, pp 37–46 (This volume).Google Scholar
© Springer Science+Business Media, Inc. 2005